Sexual Dysfunctions- Orgasm Related Disorders: (GUYS, CASE HISTORIES AND

STUDIES???)
Orgasm is a sensation of intense pleasure creating an altered consciousness state accompanied by pelvic
striated circumvaginal musculature and uterine/anal contractions and myotonia that resolves sexually-
induced vasocongestion and induces well-being/contentment. Orgasmic dysfunction is a condition that
occurs when someone has difficulty reaching orgasm. This difficulty occurs even when they’re sexually
aroused and there’s sufficient sexual stimulation. When this condition occurs in women, it’s known as
female orgasmic dysfunction. Men can also experience orgasmic dysfunction, but this is much less
common. 
There are four types of orgasmic dysfunction: Add the common situations when this occurs, statistics
Primary anorgasmia: A condition in which you’ve never had an orgasm. (explain the implications of the
same)
Secondary anorgasmia: Difficulty reaching orgasm, even though you’ve had one before.
Situational anorgasmia: The most common type of orgasmic dysfunction. It occurs when you can only
orgasm during specific situations, such as during oral sex or masturbation.
General anorgasmia: An inability to achieve orgasm under any circumstances, even when you’re highly
aroused and sexual stimulation is sufficient.
Please add the criteria for
Treatment: Please add an explanation of each of the following
 CBT- Cognitive Behavioural Therapy
 Estrogen hormone therapy/ testosterone
 Arousal oils- zestra (
MAIN OUTCOME MEASURE: 

Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion,
public presentation and debate.
RESULTS: 
Female Orgasmic Disorder, the second most frequently reported women's sexual problem is considered to be the
persistent or recurrent delay in, or absence of, orgasm following a normal sexual excitement phase that causes marked
distress or interpersonal difficulty (DSM-IV) (Why haven’t we included DSM 5 Criteria?).Empirical treatment
outcome research is available for cognitive behavioural and pharmacological approaches. Cognitive-behavioural
therapy for anorgasmia promotes attitude and sexually-relevant thought changes and anxiety reduction using
behavioural exercises such as directed masturbation, sensate focus, and systematic desensitization treatments as well
as sex education, communication skills training, and Kegel exercises. To date there are no pharmacological agents
trials (i.e., bupropion, granisetron, and sildenafil) proven to be beneficial beyond placebo in enhancing orgasmic
function in women diagnosed with Female Orgasmic Disorder.
CONCLUSIONS: 
More research is needed in understanding management of women with orgasmic dysfunction.